AAAAAA
Results:
1-7
|
Results: 7
Authors:
Eriksson, BI
Bauer, KA
Lassen, MR
Turpie, AGG
Citation: Bi. Eriksson et al., Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery., N ENG J MED, 345(18), 2001, pp. 1298-1304
Authors:
Bauer, KA
Eriksson, BI
Lassen, MR
Turpie, AGG
Citation: Ka. Bauer et al., Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery., N ENG J MED, 345(18), 2001, pp. 1305-1310
Authors:
Lassen, MR
Borris, LC
Jensen, HP
Poulsen, KA
Ejstrud, P
Andersen, BS
Citation: Mr. Lassen et al., Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty, CL APPL T-H, 6(1), 2000, pp. 53-57
Authors:
Lassen, MR
Citation: Mr. Lassen, Comparative efficacy of low-molecular-weight heparins in orthopedic surgery, SEM THROMB, 26, 2000, pp. 53-56
Authors:
Lassen, MR
Borris, LC
Backs, S
Kaltoft-Sorensen, M
Coff-Ganes, H
Jeppesen, E
Citation: Mr. Lassen et al., Clinical limitations of risk assessment models, BL COAG FIB, 10, 1999, pp. S45-S51
Authors:
Haas, S
Agnelli, G
Arcelus, JI
Davidson, BL
Lassen, MR
Planes, A
Citation: S. Haas et al., Workshop II: The future of prolonged thromboprophylaxis, BL COAG FIB, 10, 1999, pp. S103-S106
Authors:
Braat, EAM
Levi, M
Bos, R
Haverkate, F
Lassen, MR
de Maat, MPM
Rijken, DC
Citation: Eam. Braat et al., Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects, J LA CL MED, 134(2), 1999, pp. 161-167
Risultati:
1-7
|